INTRODUCTION
Soft tissue sarcoma (STS) is a term used to describe a number of different types of tumours of mesenchymal origin with similar histological features and biological behaviour (Dernell et al. 1998 , Ehrhart 2005 , Dennis et al. 2011 ). They are classically described as pseudoencapsulated masses with poorly defined margins. Because malignant tumour cells can penetrate the pseudocapsule, a surgical resection that passes through this plane can leave microscopic disease in situ, resulting in tumour recurrence (Dernell et al. 1998 ) . The extent of this recurrence-prone margin is poorly defined.
Local recurrence of tumour after surgery can develop in between 17 and 75% of all patients, with recurrence associated with more than a fivefold increased risk of death (HR 5·2; P<0·0001; 95% CI: 3·1 to 9·0) (Bostock & Dye 1980 , Kuntz et al. 1997 , Scarpa et al. 2012 . Higher rates of recurrence are reported with more aggressive (high grade) tumours and/or when surgical margins have been inadequate (Kuntz et al. 1997 , Dernell et al. 1998 , Chase et al. 2009 , McSporran 2009 , Scarpa et al. 2012 . As a consequence, wide surgical resection of 3 cm lateral margins and a deep fascial plane have been traditionally recommended for the management of STS (Dernell et al. 1998 , Ehrhart 2005 .
It is well accepted that wide or radical excision margins of STS will provide good local tumour control in most patients. With treatment, many dogs with STS can experience prolonged survival with median survival times ranging from 480 to 1796 days (Kuntz et al. 1997 , Baker-Gabb et al. 2003 , Selting et al. 2005 . Estimated 1-, 2-and 5-year survival probabilities of 94, 86 and 70%, respectively, have been reported .
However, extensive margins will not cure all patients. Metastatic disease can develop in up to 30% of patients (Bostock & Dye 1980 , Kuntz et al. 1997 , Heller et al. 2005 , Selting et al. 2005 , Stefanello et al. 2008 , Demetriou et al. 2012 , although this may be higher (41%) with high-grade disease. Furthermore, while wide margins may be achievable when tumours arise on parts of the body (e.g. the trunk) where reconstruction is possible, more than 50% of STS arise on the appendicular skeleton (Kuntz et al. 1997 , Baker-Gabb et al. 2003 , Chase et al. 2009 , Bray et al. 2014 . Wide resections at this location increase the risk that vital nerves, vascular structures, significant muscles or tendinous structures become involved in the resection, which may result in unnecessary morbidity. Adequate deep margins are also less attainable at this site. Kuntz et al. ( 1997 ) reported that for tumours of the limb, amputation did not improve survival times for patients when compared to other procedures (Kuntz et al. 1997 ) .
A Halsted-like trust in aggressive surgical margins is also weakened by results from recent studies that suggest that the extent of resection does not influence the disease-free interval or overall survival (Stefanello et al. 2008 , Chase et al. 2009 , McSporran 2009 . To confuse things further, studies have shown that an incomplete surgical margin does not necessarily mean tumour recurrence is inevitable (Kuntz et al. 1997 , McSporran 2009 ). Tumours may also recur despite histologically "clean" margins (Kuntz et al. 1997 , Banks et al. 2004 , Stefanello et al. 2008 , Chase et al. 2009 , Scarpa et al. 2012 .
Many of the answers to resolve this confusion are not available in the veterinary literature. However, a similar debate on the management of STS has occurred in the human literature (Enneking et al. 1981 , Rydholm & Rooser 1987 , Kawaguchi et al. 2004 , King et al. 2012 , and many of the treatment challenges posed by this tumour in humans are similar to those that confront the veterinary surgeon. The purpose of this review is to examine the issues affecting the management of canine STS and to evaluate the human literature for lessons that may guide future treatment directions for dogs.
Are wide resection margins still important? When considering resection margins in STS, it is important to understand the importance of both the width of the surgical margin relative to the pseudocapsule and surrounding reactive zone, and the inclusion of any defined anatomical barriers around the tumour. Musculoskeletal surgeons around the world have adopted different surgical protocols using various excisional widths, tissue barriers or a combination of both to provide guidelines for the management of human STS.
Excisional width
Possible excision margins in STS have been classified as intralesional, marginal, wide, or radical/amputation (Enneking et al. 1981 ) . Amputation was once considered the standard of care for extremity STS in humans (Enneking et al. 1981 , Kawaguchi et al. 2004 . However, in 1958, Bowden and Booher proposed a resection plan describing an "overly generous incision" and block excision of muscles at points of origin and insertion . In that study, tumour recurrence developed in 5/37 (13·5%) patients. Their results identified not only the potential for limb sparing surgery, but started a debate on "how wide" a resection was needed, to be sure of a locally curative outcome (Enneking et al. 1980 , Enneking et al. 1981 , McKee et al. 2004 , King et al. 2012 .
The focus on the importance of wide excision was supported by results indicating that disease-free and overall survival times increased with an increasing width of the surgical margin (Berlin et al. 1990 , McKee et al. 2004 , Dickinson et al. 2006 , Sampo et al. 2008 , Novais et al. 2010 , Lintz et al. 2012 .
The Scandinavian Surgical Staging System defined an "adequate margin" as a 3-cm rim of non-neoplastic tissue, which was subsequently increased to 5 cm (Trovik 2001 ) . The Japanese Orthopaedic Association (JOA) defined a curative margin as a resection margin that was greater than 5 cm beyond the reactive zone, with a wide margin being between 1 and 4 cm (Kawaguchi et al. 1995 ) .
Tissue barriers
Tissue barriers are defined as tissue that is resistant to tumour invasion, and includes muscle, fascia, joint capsule, cartilage, bone, etc (Enneking et al. 1980 ) . Tissue barriers have been further subdivided into "thick" and "thin" barriers. A thick barrier is a physically strong membranous tissue such as joint capsule, iliotibilar band, etc., while a thin barrier is a weaker membranous tissue and includes muscle, fascia, periosteum in adults, epineurium, etc.
The importance of tissue barriers is based on the recognition that during growth, STS tend to respect these boundaries and will preferentially expand within the structure of origin along the path of least resistance (Enneking et al. 1981 ) . If spread beyond the originating structure does occur, the pathway is usually via perforating vascular channels (or surgically created openings) and occurs late in the disease course (Enneking et al. 1981 ) . Inclusion of various tissue barriers in the resection provided additional certainty for the completeness of resection.
The JOA system attempted to account for the effects of various tissue barriers that may impact on tumour infiltration (Kawaguchi et al. 1995 , Kawaguchi et al. 2004 . When defining the "5 cm margin," these barriers were converted into "normal tissue equivalents": thus, a thick barrier was considered equivalent to 3 cm of normal tissue and a thin barrier was converted to 2 cm of normal tissue. Joint cartilage was considered to be the equivalent of 5 cm of normal tissue. If the tumour adhered to one surface of the barrier without penetrating through it, 1 cm was deducted from the normal tissue equivalent.
Examination of the importance of excision width in the human literature yields conflicting results (Enneking et al. 1981 , Rydholm & Rooser 1987 , Kawaguchi et al. 2004 , King et al. 2012 . In two studies, no tumours recurred when resection margins were wider than 2 cm (Dickinson et al. 2006 , Novais et al. 2010 . In a study of 559 patients by the Scandinavian Sarcoma Group local recurrence occurred in 20% of patients treated with wide (3 cm) margins (Trovik 2001 ). An analysis of 360 highgrade STS operated using the JOA system revealed tumour recurrences occurred in 14% of patients with curative (5 cm) margins and 14% with adequate wide (2 cm) margins (Kawaguchi et al. 1995 ) . Other authors have described tumour recurrence in about 10% of extremity STS despite clean surgical margins of between 2·5 and 4 cm (Sampo et al. 2008 ) .
Taken overall, evidence from human papers tends to support the notion that resections based solely on width have not led to demonstrably improved cure rates sufficient to justify the increased morbidity that is incurred (Stojadinovic et al. 2002b , McKee et al. 2004 , King et al. 2012 , Nurkin & Kane Iii 2012 . In human STS surgery, the issue of "how much to resect" has been largely circumvented by the routine inclusion of radiotherapy (adjuvant or neoadjuvant) into the context of "standard treatment" (Rosenberg et al. 1982 , Karakousis et al. 1986 , Pisters et al. 1996 , Zagars et al. 2003a , and local control rates of >80% are now reported in most modern series involving such combination therapy (Miller et al. 2015 ) .
In canine STS, a similar debate on resection margins has also occurred. Bostock & Dye ( 1980 ) were the first to describe high rates of recurrence following surgical resection of STS, with local recurrence developing in more than 60% of patients with high-grade tumours (Bostock & Dye 1980 ) . A subsequent study by Kuntz et al. ( 1997 ) suggested that good outcomes could be achieved with wide resection margins (Kuntz et al. 1997 ) . In that paper, narrow resection margins and a higher tumour grade were associated with poorer outcomes; other authors subsequently confirmed these prognostic findings (Baker-Gabb et al. 2003 , Heller et al. 2005 . As a consequence of these studies, surgical resection with 3 cm lateral margins and a deep fascial plane have been traditionally recommended for the management of STS (Dernell et al. 1998 , Ehrhart 2005 .
Several publications over the last 10 years have challenged this generic advice. Stefanello et al . ( 2008 ) reported a local recurrence rate of just 10·8% (follow-up 210 to 2202 days) in 35 dogs with low-grade spindle cell tumours of the extremities treated by marginal excision only (Stefanello et al. 2008 ) . In another prospective clinical study, Banks et al. ( 2004 ) achieved 100% local disease control and 93% one-year disease free interval in 14 dogs with 1 cm lateral margins and a single fascial plane beneath the tumour. (Banks et al. 2004 ) . However, in that paper, patient follow-up times were only 12 months, which is inadequate for STS. In two papers examining outcomes for dogs with STS treated in first opinion practice, local recurrence rates of 20·8% were reported, despite marginal or narrow resections being performed in 59 to 77% of cases (Chase et al. 2009 . Median follow-up in these papers were 875·5 and 785 days.
Clean resection is the goal Irrespective of the actual surgical "excision margin", demonstration of a histological margin that is clear of tumour cells is considered the best predictor for improved local tumour control (Stojadinovic et al. 2002a , Banks et al. 2004 , Dickinson et al. 2006 , Chase et al. 2009 , Dennis et al. 2011 , Nurkin & Kane Iii 2012 , Qureshi et al. 2012 , Scarpa et al. 2012 . In human cancer treatments where adjuvant radiotherapy is combined with surgery, margins are graded as "R0" when no cancerous cells are seen microscopically, also defined as a clean margin. An incomplete margin can be graded as "R1" when cancer cells remain detectable on microscopic examination and "R2" when grossly detectable tumour remains visible.
There is general consensus from veterinary and human studies that a clean histologic margin is associated with significantly improved survival and prolonged tumour-free intervals (Stojadinovic et al. 2002a , Banks et al. 2004 , Dickinson et al. 2006 , Chase et al. 2009 , Dennis et al. 2011 , Nurkin & Kane Iii 2012 , Qureshi et al. 2012 , Scarpa et al. 2012 . Kuntz et al. ( 1997 ) reported tumour recurrence was 10·5 times (95% CI 1·33 to 82·42) more likely to occur following resection with incomplete margins (Kuntz et al. 1997 ) . However, the precise width of clean margin necessary to completely eliminate recurrence has not been investigated in the dog. In one study, no recurrences were observed when >3 mm of normal tissue was found between the tumour and surgical margins on histological review (Stefanello et al. 2008 ) . Unfortunately, different studies use different criteria to define a "clean" margin (ranging from 1 to 10 mm), making it difficult to compare outcomes (Dennis et al. 2011 ) .
The same question has been evaluated in human STS. In a study involving 248 patients, resection margins were categorised as either positive, less than 2 mm, between 2 mm and 2 cm and greater than 2 cm (Novais et al. 2010 ). This study showed that patients with either positive margins or margins less than 2 mm were more likely to have local recurrence, but there was no difference in rates of local recurrence between patients with margins between 2 mm and 2 cm and patients with margins greater than 2 cm. In other studies, the incidence of recurrence was the same for patients with <1 mm histological margins as it was for patients with margins >1 mm. (King et al. 2012 ) Perversely, an incomplete surgical margin does not mean tumour recurrence is inevitable. Published recurrence rates for canine STS following incomplete or close margins range from just 17% (2/12) to 28% (10/36) (Kuntz et al. 1997 , McSporran 2009 ). Similar findings have been reported for human STS. In a large series of 2084 patients, 72% of patients with positive margins exhibited no recurrence with a median follow-up of 50 months (Stojadinovic et al. 2002b ) . Tumours may also recur despite histologically "clean" margins. In dogs, Kuntz et al. ( 1997 ) described recurrence in 8% of patients despite a clean resection being reported (Kuntz et al. 1997 ) . Similarly, other authors have reported recurrences in 5 to 22% of canine patients with apparently clean resections (Kuntz et al. 1997 , Banks et al. 2004 , Stefanello et al. 2008 , Chase et al. 2009 , Scarpa et al. 2012 . In human studies, recurrence rates of 11·8% have been reported despite "clean" histological resections (Stojadinovic et al. 2002b ) .
These discordant results pose an important question: why does outcome not always conform to an increasing resection margin? Some authors have questioned the limitations and reliability of margin interpretation in tumour histopathology, which are likely to be significant (Giudice et al. 2010 , Kamstock et al. 2011 . Other considerations include the heterogeneity of the tumour population, the structure of the tumour pseudocapsule and aspects of tumour biology that may play an equally important role in influencing tumour recurrence (Beacham & Cukierman 2005 , Martano et al. 2011 ).
Limitations of margin assessment
"Clean surgical margins" have become the ultimate goal of the oncologic surgeon and a key driver for identifying the right balance of surgical aggression to ensure that every last tumour cell is removed from the wound bed (Eward et al. 2013 ) .
However, the histological assessment of surgical margins as an indicator of complete tumour removal in all planes can be highly flawed, either as a consequence of processing methodology or the practical realities of a commercial laboratory service (Dennis et al. 2011 , Kamstock et al. 2011 . For example, consider a 1 cm STS that has been removed with 2 cm elliptical margins. This will result in a pathological specimen measuring about 3×2×1 cm. If every single edge of the specimen was to be examined, and cut into 5-micron sections, it would take about 4000 histological sections to examine the entire tissue. In most commercial veterinary laboratories, reporting is performed on just three-to-six sections. Pathologists therefore need to be strategic in assessing which sections of a large tumour bulk to evaluate (Kamstock et al. 2011 ) . Because of these limitations, margin assessment can yield falsenegative results as the entire three-dimensional specimen cannot be fully evaluated. False-positive results can also occur due to deformation of the tissue during fixation (Dennis et al. 2011 , Kamstock et al. 2011 . Recommendations have been published to improve consistency in histologic processing and reporting (Dennis et al. 2011 , Kamstock et al. 2011 , Bray 2016 , and are discussed in the first review article in this series. The impacts of these processing challenges on histologic accuracy for the reporting of margins have not been extensively investigated in canine STS. In one recent study, partial (6/15) or complete (3/15) disagreement on different diagnostic criteria was reported between two pathologists for mesenchymal tumours, but disagreement on margin evaluation (clean versus dirty) occurred in only 1/15 case (Regan et al. 2015 ). An excellent review on the similar challenges in human cancer is available (Emmadi & Wiley 2012 ) .
Another limitation to the accuracy of margin assessment is the ability of the histologist to identify some fascial tissues as a distinctive structure. A fascial layer is widely acknowledged as a crucial boundary to the deep excision margin (Kuntz et al. 1997 , Dernell et al. 1998 . While a fascial layer may appear distinct to the surgeon, the same structure can sometimes be difficult to identify microscopically. There is controversy among anatomists as to what constitutes fascia (Kumka & Bonar 2012 , Schleip et al. 2012 , Stecco 2014 (Schleip et al. 2012 ) . The distinction is one of form and function; traditional systems originated from gross dissection studies, whereas advances in imaging and three-dimensional analysis has prompted a desire to identify fascia as a body-wide interconnected tensional network, with certain structural components. The FCAT system is considered more accurate for histologic analysis, but the proposed reclassification of certain tissues has not been uniformly adopted. The impact of these distinctions on the barrier function of certain fascial tissues is unknown.
Tumour heterogeneity: are we all treating the same disease?
Much of the evidence for the management of STS has been derived from publications generated in referral or academic practice. However, a bias for more lower-grade tumours being managed in first opinion practice seems to exist (Chase et al. 2009 . In the 1980 paper by Bostock and Dye, the proportion of low-grade tumours was 54%, with intermediate and high-grade tumours comprising 21 and 25% of the study population, respectively (Bostock & Dye 1980 ) . That paper was published at a time when veterinary oncologic surgery in the UK was in its infancy, and specialist referral practices were uncommon. In a more recent study performed on tumours operated in first opinion practice in the UK more than 30 years later, 66% of tumours were classified as low grade, with just 6·3% being highgrade . By comparison, when studies are derived from a referral population of tumours, high-grade tumours tend to be three times more common (i.e. between 17 and 29% of the sample population) (Kuntz et al. 1997 , Banks et al. 2004 , Heller et al. 2005 . This selection bias may occur as tumours that have a more aggressive clinical appearance (e.g. large size, recent rapid growth, or a fixed and immobile characteristic) are more likely to be referred for treatment at a specialist centre, or are not offered surgical care at all. (Fig 1 ) This bias is important as, in 2009, McSporran showed that histologic grade is a strong predictor of recurrence for marginally excised subcutaneous STS, with 7, 34 and 75% recurrence rates for low, intermediate and high-grade tumours, respectively. Other authors have shown that the extent of resection alone is not the critical determinant of outcomes, particularly when the treated population is biased towards predominately low-grade lesions (Stefanello et al. 2008 , Chase et al. 2009 . Human studies have also shown that smaller margins may provide safe outcomes for low-grade tumours only (Kawaguchi et al. 1995 , Engellau et al. 2007 , Lintz et al. 2012 .
The pseudocapsule
The pseudocapsule is a renowned feature of the STS and creates a discernible (and tantalising) circumscription to the tumour (Enneking et al. 1981 ) . The pseudocapsule is formed initially by the compression and atrophy of the surrounding tissue as the tumour expands centrifugally. With continued expansion of the tumour, a reaction can develop between the capsule and normal tissue, which includes mesenchymal cell proliferation, influx of inflammatory cells, haemorrhage, tissue oedema, vascular neogenesis and other granulomatous changes (Enneking et al. 1981 , Liu et al. 2008 ). This area is termed the reactive zone and may sometimes be visible grossly as a discoloured area that surrounds the tumour.
Small buds of sarcoma cells regularly extrude through the reactive zone and form small isolated nodules (satellite nodules or skip metastases) (Enneking et al. 1981 , Voros et al. 1998 , White et al. 2005 , Liu et al. 2008 , Kind et al. 2009 ). With time, these isolated nodules enlarge and ultimately coalesce with the parent mass, creating a lobulated appearance to the lesion. Typically, a gross circumscription develops between the zones of compression and reaction, providing a tempting plane for dissection. However, evidence suggests this boundary is incomplete and cleavage at this site will likely leave microscopic and possibly gross tumour in the wound (Enneking et al. 1981 , Ehrhart 2005 , Liptak & Forrest 2013 .
In some tumours, discrete microscopic clusters of neoplastic cells may extend some distance from the pseudocapsular boundary, separated from it and the reactive zone by microscopically normal tissue. In one human study, microscopic tumour nodules were identified between 1 and 4 cm from the main mass in 30% of cases (White et al. 2005 ) . Satellite nodules are more commonly observed with high-grade lesions; with low-grade tumours, these satellite nodules are almost never reported beyond the reactive zone (Enneking et al. 1981 , Azzarelli 1993 .
Histological descriptions of human STS support the varying integrity of the pseudocapsule to penetration by tumour cells, with the integrity reducing with increasing tumour grade. By examining whole tumour sections, Engellau et al. ( 2007 ) described the peripheral growth pattern of STS as either "pushing" (if no evidence of infiltrative growth was seen) or "infiltrative" (if the tumour contour was poorly defined, or satellite nodules were present) (Engellau et al. 2007 ) . While a pushing growth pattern was more commonly observed with low-grade tumours, a proportion (18%) of high-grade tumours also displayed this characteristic. In Engellau ' s study of 140 tumours, none of the tumours with a pushing growth pattern recurred locally, whereas in those with an infiltrative growth pattern local recurrence developed in 23% (6/26) after marginal excision and 23% (13/56) after wide excision. In a similar study, Lintz et al. ( 2012 ) reported an almost sevenfold increase (HR=6·7, P=0·005; 95% CI 1·82 to 26·13) in the likelihood of local recurrence if the tumour had a poorly contoured margin (with or without the presence of nodules) on histology (Lintz et al. 2012 ) . Similar studies have not been performed on canine STS.
The pseudocapsule therefore appears to be a complex and amorphous structure. (Fig 2 ) In some tumours, the fibrous pseudocapsule may actually provide an effective barrier against tumour growth and infiltration but this probably holds true for a proportion of (mostly) low-grade lesions only (Enneking et al. 1981 , Takahashi et al. 1993 , Liu et al. 2008 . In those instances, successful local control could indeed be achieved with excision of the mass including a narrow rim of normal tissue, as has been suggested by some authors (Stefanello et al. 2008 , Chase et al. 2009 . However, in other tumours, the reactive zone that surrounds the pseudocapsule is an area of nascent and evolving neoplastic activity, with isolated clusters of neoplastic cells and a permissive stromal microenvironment that supports cancer initiation, neovascularisation and tumour migration. In these cases, there is a higher likelihood for tumour recurrence if the plane of surgical excision passes through this area (White et al. 2005 , Kind et al. 2009 ). The description of isolated tumour nodules located several centimetres from the tumour pseudocapsule may also provide an explanation for why local recurrence could still occur following complete removal of the gross tumour (Enneking et al. Much of the evidence for the management of STS has been derived from publications generated in referral or academic practice. In this "selected" population, high-grade tumours are up to three times more common than the tumour population treated in first opinion practice. This graph highlights the proportion of high-grade tumours in study populations from purely first-opinion practice and referral practices. (references (Bostock & Dye 1980 , Kuntz et al. 1997 , Banks et al. 2004 , Heller et al. 2005 , Bacon et al. 2007 Voros et al. 1998 , White et al. 2005 ; there are likely complex mechanisms at play in the tumour microenvironment that impact on which tumours recur, and those that do not (Beacham & Cukierman 2005 , Lu et al. 2012 , Bolouri 2015 .
In human STS, magnetic resonance imaging (MRI) has been shown to allow the integrity of the pseudocapsule to be directly assessed (Rydholm & Rooser 1987 , Liu et al. 2008 , Kind et al. 2009 , Richards 2011 ). On T2-weighted MRI images, the pseudocapsule can have a prominent low signal intensity band. In one study, this appearance correlated significantly with the histological grade of the STS in 22/59 (37·3%) cases (P<0·05) (Liu et al. 2008 ) . Most of the cases with a peritumoural low signal intensity capsule-like sign were grade 1 tumours, while most of the cases without this sign were grade 2 to 3 tumours. Several authors have proposed that the stronger peritumoural low signal band indicates the pseudocapsule is sufficiently robust to be an effective barrier against tumour infiltration. In those cases, a marginal resection could be performed to obtain a relatively safe margin (Liu et al. 2008 , Kind et al. 2009 , Richards 2011 , Zhao et al. 2014 . This finding may have useful implications for planning surgical margin, but has not been assessed or validated in canine patients.
Canine STS: future directions
Surgical margins in sarcoma: is it quality not quantity?
Conventional surgical technique for sarcoma resection involves defining a desired surgical margin about the tumour and then removing tissue "en bloc" within that defined boundary (Dernell et al. 1998 , Liptak 2009 , Huth 2010 , Farese & Withrow 2013 . Muscles that extend across the resection boundary are cut midbody; nerves or blood vessels that branch into the resection field are similarly cut at the measured border of the surgical margin. With en bloc resection, it is presumed that if satellite nodules are present, they are contained within the resected block of tissue. Because this extent cannot be reliably predicted for each individual tumour, prescribing wide surgical margins for all tumours became the standard of care to reduce the risk of tumour recurrence (Bostock & Dye 1980 , Kuntz et al. 1997 , Ehrhart 2005 , Liptak & Forrest 2013 .
In 1980, Enneking proposed a new classification system for the resection of human musculoskeletal tumours (Enneking et al. 1981 ) . He argued that wide local resection -with an arbitrary measure of normal tissue about the tumour -carried a proportional risk that satellite nodules would be left behind. This was particularly true for high-grade tumours (Enneking et al. 1981 ) . Instead, he favoured radical local resection , with removal of a whole "compartment" of normal tissue (e.g. a single muscle or a group of muscles surrounding a central tumour, removed from origin to insertion) about the lesion. This resection strategy ensured that the tumour was entirely contained within robust anatomic barriers leaving no satellite nodules behind.
Compartmental tumour excision has been shown to provide significantly improved patient survival times and reduced tumour recurrence compared to patients undergoing conventional wide local (en bloc) excision (Enneking et al. 1980 , Enneking et al. 1981 , Rydholm & Rooser 1987 , Stotter et al. 1990 , Azzarelli 1993 , Karakousis et al. 1998 , Enneking 2009 , Fisher et al. 2011 ).
FIG 2 . The structure and composition of the pseudocapsule may prove vital in determining the outcome following surgical resection. For many lowgrade lesions (top images), the compressed fibrous zone may provide an effective barrier against tumour growth and infiltration. On histologic studies in human STS, none of the tumours with a pushing growth pattern recurred locally. However, many higher-grade lesions (lower images) will expand faster than the fibrous capsule can form, leading to infiltration by sarcoma cells. The reactive zone is an area of nascent and evolving neoplastic activity. Sarcoma cells can be found several centimetres beyond the pseudocapsule surrounded by normal tissue One author recently described compartmental tumour excision as a paradigm shift from circumferential to longitudinal resection, and that it offered the following advantages (Calabrese et al. 2009 ):
(1). Allows complete removal of an involved muscle compartment, even if only partially affected by the tumour, and more adequately addresses the potential spread of the micrometastatic satellite nodules contained within an ill-defined anatomical boundary around the tumour (2). Enables the surgeon to perform a radical oncological resection while at the same time eliminating non-selective demolition. (3). With preoperative coaxial imaging, the anatomical relationship of the tumour with surrounding structures will improve surgical planning and reconstruction efforts, and may allow true anatomical boundaries of a tumour to be identified and exploited.
Enneking ' s model has fallen out of favour with human musculoskeletal oncologists for a variety of reasons, but mostly due to awareness of the value of adjuvant RT in management of satellite nodules to improve local control while limiting surgical aggression (Rosenberg et al. 1982 , Pisters et al. 1996 , Miller et al. 2015 . However, in veterinary surgery -where curative-intent surgery is often the only treatment modality employed -aspects of Enneking ' s observations may warrant further attention. Many canine STS arise from the subcutaneous space, so the model will not be directly applicable in every instance. However, increased use of preoperative imaging modalities should allow the true anatomical boundaries of a tumour to be identified and exploited when devising the treatment plan (Bray & Polton 2016 , Bray 2014 ; Fig 3 ) .
Can the pseudocapsule be sterilised?
The administration of chemotherapy prior to surgical resection of the tumour -neoadjuvant therapy -is now an accepted protocol for a variety of tumour types in humans (Gortzak et al. 2001 , Wodajo et al. 2001 , Hohenberger & Wysocki 2008 , Lietman 2010 , Fujiki et al. 2011 . It is suggested that neoadjuvant chemotherapy can achieve better tissue penetration, as the microvasculature of the tumour has not been disrupted by surgery. Histological differences have also been observed in the pseudocapsule between patients who received neoadjuvant chemotherapy and those who did not (Gitelis et al. 1989 , Wodajo et al. 2001 . In one study, the tumour pseudocapsule in patients receiving chemotherapy was converted into a thick, collagenised capsule that did not contain viable tumour cells (Wodajo et al. 2001 ) . Similar changes have been observed following neoadjuvant radiotherapy (Gitelis et al. 1989 ) . These results suggest that neoadjuvant therapy may help confine the tumour extension to a more definable boundary, thereby improving the odds for complete surgical excision. Evidence from the veterinary literature is limited (Martano et al. 2005 , Bray & Polton 2016 , but may warrant further attention.
Radiotherapy is considered an integral component of local therapy in human STS management (Rosenberg et al. 1982 , Pisters et al. 1996 , Zagars et al. 2003a , Miller et al. 2015 . Evidence for the importance of combined therapy was first demonstrated in a National Cancer Institute study that compared outcomes for 43 patients with extremity STS after either amputation versus wide local excision followed by 60 to 70 Gy of radiation (Rosenberg et al. 1982 ) . This strategy preserved limb function and provided equitable rates of local control with, importantly, no change in overall or disease-free survival. Subsequent studies have confirmed these findings for both adjuvant and neoadjuvant radiotherapy (RT), as well as for external beam RT and brachytherapy (Karakousis et al. 1986 , Pisters et al. 1996 , Zagars et al. 2003a .
In veterinary patients, several studies have demonstrated good efficacy for curative intent RT with daily fractions and a total dose above 50 Gy (Forrest et al. 2000 , McKnight et al. 2000 . In these studies, radiotherapy was performed after an "unplanned" resection that resulted in an incomplete margin. In human STS, patient survival and local disease-free status remain compromised even if full oncological management is employed after unplanned excision of extremity STS (Chen et al. 2011 , Qureshi et al. 2012 . However, patients with "planned positive margins" can have equivalent outcomes to patients with negative margins after surgery/RT (Pisters et al. 1996 , Miller et al. 2015 . In a prospective veterinary study, intentional marginal excision was performed prior to four weekly doses of RT (8 to 9 Gy per dose) and a total treatment dose of 32 to 36 Gy (Demetriou et al. 2012 ) . Histological margins after surgery were judged as incomplete in 100% of cases. Reasonable control was achieved with local tumour recurrence developing in 10/56 (18%) dogs, and a 1-, 3-and 5-year estimated recurrence rates of 19, 30 and 35%, respectively, but no control population was available. Further veterinary studies are required to enable better understanding of which patients are most likely to benefit from RT. Demonstration of a histological margin that is clear of tumour cells is currently the best predictor of local recurrence (Stojadinovic et al. 2002a , Banks et al. 2004 , Dickinson et al. 2006 , Chase et al. 2009 , Dennis et al. 2011 , Nurkin & Kane Iii 2012 , Qureshi et al. 2012 , Scarpa et al. 2012 . However, such a measure requires surgery to have already been performed, and fails to address the key issue of defining the resection margins necessary for successful treatment and tumour-free recovery.
The ability to accurately identify the tumours that are more likely to recur after surgical resection would greatly assist surgical planning. The currently known prognostic factors for STS include tumour grade, mitotic index and the completeness of resection (Dennis et al. 2011 ) . Slow tumour growth, small size and lack of recurrence are also surrogate indicators of less aggressive behaviour of that tumour (Chase et al. 2009 ). However, considerable deficiencies remain in our ability to accurately determine the optimal surgical dose and prognosis for an individual patient.
Currently, histological grade is the most validated criteria to predict outcome following surgery in canine patients (Kuntz et al. 1997 , McSporran 2009 . Unfortunately, the accuracy of pretreatment biopsies at determining grade is limited. In one study, 29% of pretreatment biopsies underestimated and 12% overestimated the final histological grade assigned to the tumour after resection (Perry et al. 2014 ) . These authors concluded that pretreatment biopsies -regardless of technique -are relatively accurate at distinguishing high-from low-grade sarcoma, but a pretreatment result of "low-grade" should be viewed with caution.
Similar limitations in the accuracy of pretreatment grading were also recognised for human STS (Deyrup & Weiss 2006 ) . Because knowledge of histological grade was recognised as extremely important in determining treatment solutions for an individual patient, considerable effort has been expended to improve the utility of pretreatment analysis for the STS surgeon (Jansen-Landheer et al. 2009 , Blay et al. 2014 , Noujaim et al. 2016 . Results from human STS suggest that core biopsy provides reliable and comparable results to open biopsy and accurately determined high versus low grade in 93% of cases (Ball et al. 1990 , Heslin et al. 1997 . Similar levels of reliability should be the goal for veterinary pathologists.
Cancer is an evolutionary process involving somatic genetic and epigenetic changes, ultimately leading to clonal expansion by tumour cells (Hanahan & Weinberg 2000 ) . Progressive acquisition or abrogation of important cellular mechanisms by the tumour cell allows it to proliferate uncontrollably. Development of a clinically relevant neoplasm requires close cooperation and biochemical interactions with other tumour clones, the extracellular matrix, hormones, soluble factors and stromal tissues within the tumour microenvironment (Pietras & Ostman 2010 , Pickup et al. 2014 . Within different STS, the aggregated signature of cytokines, hormones and receptors that arise from variably deranged gene regulatory networks (GRN) will lead to different influences on the local tissue. It is hypothesised that certain GRN profiles will be more associated with key hallmark traits of the tumour (Wang et al. 2015 ) . For the sarcoma, these traits may include (1) the ability for cells to migrate into the surrounding tissue; (2) the ability to develop an independent blood supply (angiogenesis) and (3) for the pseudocapsule to be an effective barrier to tumour penetration. By correlating the genetic fingerprint of the tumour with key phenotypic attributes pertinent to prognosis (e.g. recurrence after surgery, metastasis, histologic characteristics), it should be possible to identify genetic markers that may predict outcome or provide targets for novel treatment options (Wang et al. 2015 ) .
Genomic analysis of canine STS currently remains very limited. In 2010, Mahoney et al . attempted to determine the feasibility of using cDNA microarray and quantitative real-time PCR analysis to assess gene expression patterns in metastatic versus non-metastatic STSs (Mahoney et al. 2010 ) . Differential gene expression was validated for five genes that were upregulated in metastatic tumours, with Sprouty-2 showing the greatest relative expression (a 96-fold higher expression in metastatic than in nonmetastatic tumours). Chi et al. ( 2011 ) used integrative analysis of gene expression and diffusion-weighted MRI to identify a significant correlation between tumour responses with genes involved in VEGF signaling, telomerase, DNA repair, and inflammation (Chi et al. 2011 ) . This study identified two distinct tumour subtypes with significant differences in their gene expression and treatment response.
Current evidence suggests it is not the extent of resection that influences successful patient outcome, but the biological behaviour of the tumour (Weitz et al. 2003 ) . This highlights the need for more reliable and objective prognostic markers to be developed in canine and human STS (Pisters et al. 1996 , Yudoh et al. 2001 , Gustafson et al. 2003 , Zagars et al. 2003b , Engellau et al. 2005 , Matsumine et al. 2007 , Kilvaer et al. 2010 , Dennis et al. 2011 , Sampo et al. 2012 , Kondo et al. 2013 . If the gene signatures of tumours with either favourable or aggressive behaviour could be predicted prior to surgery, more appropriate and targeted treatment could be provided.
CONCLUSION
In 1981, it was recognised that the "biologic aggressiveness of a STS is the key factor in the selection of the surgical margin required to achieve local control" (Enneking et al. 1981 ) . Almost half a century later, we continue to struggle with the same dilemmas in the management of canine STS. Because there are no diagnostic tests that can reliably predict the amount of surgical margin required for a particular tumour, there may be a mismatch between treatment and disease: some dogs are overtreated for their disease, resulting in large wound reconstructions or amputation when smaller surgical margins would have been effective. Other dogs are undertreated and suffer tumour recurrence and premature death due to inadequate initial treatment. The importance of combination therapy using surgery and radiotherapy, now a mainstay in human STS, has received little attention in the veterinary literature.
